Thomas King is a final year PhD candidate at the University of New South Wales Sydney - School of Biomedical Sciences investigating the use of apolipoprotein mimetic peptides as a potential disease modifying therapy for Type 1 Diabetes.

Ziyi Wang is a PhD candidate at the University of Queensland (QAAFI), researching glycogen structure since 2017. He specializes in glycogen extraction and structural analysis, exploring its role in liver diseases like diabetes and NAFLD. He has published 13 papers, including 8 as first author.

The author is in his second year of PhD studies. His project is focused on the fine structure of glycogen particles and their relationship with diabetes.

Jing Wu, Shiyi Sun, Xingwu Ran, Members of the Innovation Center for Wound Repair, Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University.

Dr Xiaoyu Wang’s research interests focus on liver fibrosis in non-alcoholic fatty liver disease in both animal and human research studies, including the role of growth factors in the progression of NASH and its possible underlying mechanisms

Dr Victoria McCreanor is an experienced health economist and currently working at HMRI as Acting Associate Director of Health Economics.

Melkam Kebede is a cell biologist with a strong interest in understanding the cause of reduced glucose stimulated insulin secretion in type 2 diabetes. She heads the Islet Biology and Metabolism laboratory at the Charles Perkins Centre, University of Sydney. Melkam studies the pancreatic beta-cell with specific interests in understanding the mechanisms behind insulin secretory granule biogenesis, maturation, stability and targeting for secretion. Her laboratory uses a combination of mass spectrometry, flow cytometry, microscopy, cell and molecular biology approaches to help understand these processes in cell and animal models of type 2 diabetes. Her research has been funded by Diabetes Australia Research Program and the NHMRC project and Ideas grants.